510(k) Report

510(k) · Cleared

Cleared

Modification to Accu-Chek GO System

K051592510(k) TraditionalCleared Sep 2, 200579-day reviewClass II21 CFR 862.1345

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · LFR Glucose Dehydrogenase, Glucose

Cleared on Sep 2, 2005 as substantially equivalent to K040796 (Roche Diagnostics Corp., 2004) after a 79-day review. Its family tree reaches back 2 generations to 2003.

Decided
Sep 2, 2005
Review
79 days
Class
Class II
Product code
LFR
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K031755 (2003). No later device cites it as a predicate yet.

  1. Root · 2 generations backK031755 Accu-Chek Compact Test StripRoche Diagnostics Corp. · 2003
  2. 1 generation backK040796 Accu-Chek GO SystemRoche Diagnostics Corp. · 2004 · Recalled
  3. This deviceK051592 Modification to Accu-Chek GO SystemRoche Diagnostics Corp. · 2005
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K031755Accu-Chek Compact Test StripRoche Diagnostics Corp.2003—
−1K040796Accu-Chek GO SystemRoche Diagnostics Corp.20042
0 (this device)K051592Modification to Accu-Chek GO SystemRoche Diagnostics Corp.2005—
FIG. 1 — Lineage of K051592, 2003–2005Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040796Accu-Chek GO System
Summary page 1
…(21 C.F.R. § 862.1345)(75LFR) 3) Predicate We claim substantial equivalence to the current legally marketed Accu-Chek device Go System (K#040796). 4) Device Instrument Operating Principle -- photometry Description Reagent Test Principle -- glucose dehydrogen…
Roche Diagnostics Corp.20042

Also cleared against K040796: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 2 years and passes through 1 company; a new generation was cleared every 1.4 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 1 other device also cites its predicate K040796.

How does its category compare?

All LFR devices

LFR Glucose Dehydrogenase, Glucose: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFR

1in 2015

2007: 12009: 12011: 62012: 132013: 32014: 32015: 1
2007high 13 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFR

161in 2014

2011: 296 days median2012: 152 days median2013: 212 days median2014: 161 days median
2007high 296 (2011) · low 152 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LFR

1in 2012

2007: 32008: 12009: 42011: 12012: 1
2007high 4 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFR

827in 2025

2007: 23,8192008: 6,5842009: 10,8232010: 4,8652011: 3,8022012: 3,3412013: 3,8212014: 3,9602015: 3,3662016: 2,1452017: 1032018: 1082019: 1082020: 1322021: 1642022: 1012023: 1032024: 1712025: 827
2007high 23,819 (2007) · low 101 (2022)2025

MAUDE reports naming product code LFR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—323,819
20080—16,584
20091—410,823
20100—04,865
2011629613,802
20121315213,341
2013321203,821
2014316103,960
20151—03,366
20160—02,145
20170—0103
20180—0108
20190—0108
20200—0132
20210—0164
20220—0101
20230—0103
20240—0171
20250—0827
20260—0—

What is it indicated for?

The Accu-Chek Go system is designed to quantitatively measure the concentration of glucose in whole blood by persons with diabetes or by health care professionals for monitoring glucose in the home or in health care facilities. The device is indicated for professional use and over-the-counter sale.

Professionals may use the test strips to test capillary, venous and arterial blood samples; lay use is limited to capillary whole blood testing.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K051592: Modification to Accu-Chek GO System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K051592

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026